retatrutide vs tirzepatide efficacy vs. for Weight Loss Semaglutide vs. Tirzepatide vs. Retatrutide:

Realistic expectations: a month-by-month summary Here is the consolidated view of what to expect, distilled from clinical trials and real-world data: These ranges assume eventual dose escalation to 10 to 15 mg

The SURMOUNT-1 trial showed 16% average weight loss at 5 mg weekly over 72 weeks

The addition of the glucagon component is designed to potentially increase energy expenditure and improve liver fat metabolism

Subjective experience: these men often describe it as finally seeing the body they knew was under there

It slows down how quickly the stomach empties

Many patients experience improved self-esteem, better mobility, and enhanced quality of life